APO Research
Talk to an analyst

APO RESEARCH · REPORT

Specific IgE Blood Based Allergy Testing

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Specific IgE Blood Based Allergy Testing Market Outlook and Growth Opportunities 2026

3 May 2026192 pages

Choose your research edition.

Industry ResearchSpecific IgE Blood Based Allergy Testing Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Specific IgE Blood Based Allergy Testing Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Specific IgE Blood Based Allergy Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Specific IgE Blood Based Allergy Testing Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Specific IgE Blood Based Allergy Testing Market Analysis and Forecast 2026-2032220 pages · $4,950 USD

Market perspective

The global Specific IgE Blood Based Allergy Testing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Specific IgE Blood Based Allergy Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Specific IgE Blood Based Allergy Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Specific IgE Blood Based Allergy Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Specific IgE Blood Based Allergy Testing market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Specific IgE Blood Based Allergy Testing market include Phadia (Thermo Fisher Scientific), Medwiss Analytic, Euroimmun, Quest Diagnostics, Eurofins Biomnis, Siemens Healthineers, Labcorp, Novartis and Omega Diagnostics, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Specific IgE Blood Based Allergy Testing market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Specific IgE Blood Based Allergy Testing and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Specific IgE Blood Based Allergy Testing revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Specific IgE Blood Based Allergy Testing market.

Specific IgE Blood Based Allergy Testing Segment by Company

Phadia (Thermo Fisher Scientific)

Medwiss Analytic

Euroimmun

Quest Diagnostics

Eurofins Biomnis

Siemens Healthineers

Labcorp

Novartis

Omega Diagnostics

Minaris Medical America

MacroArray Diagnostics

DST

HYCOR Biomedical

Everlywell

Abionic

Diagnostic Solutions Laboratory

MosaicDX

Lifelab Testing

HOB Biotech Group

Shenzhen Biocup Biotech

Hangzhou Zheda Dixun Biological Gene Engineering

ACON Biotech

Specific IgE Blood Based Allergy Testing Segment by Type

ELISA

FEIA

Others

Specific IgE Blood Based Allergy Testing Segment by Application

Hospitals

Clinics

Clinical Laboratories

Others

Specific IgE Blood Based Allergy Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Specific IgE Blood Based Allergy Testing status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Specific IgE Blood Based Allergy Testing key companies, revenue, market share, and recent developments.

3. To split the Specific IgE Blood Based Allergy Testing breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Specific IgE Blood Based Allergy Testing market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Specific IgE Blood Based Allergy Testing significant trends, drivers, influence factors in global and regions.

6. To analyze Specific IgE Blood Based Allergy Testing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Specific IgE Blood Based Allergy Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Specific IgE Blood Based Allergy Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Specific IgE Blood Based Allergy Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Specific IgE Blood Based Allergy Testing industry.

Chapter 3: Detailed analysis of Specific IgE Blood Based Allergy Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Specific IgE Blood Based Allergy Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Specific IgE Blood Based Allergy Testing in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Specific IgE Blood Based Allergy Testing Industry Trends Table 2. Specific IgE Blood Based Allergy Testing Industry Drivers Table 3. Specific IgE Blood Based Allergy Testing Industry Opportunities and Challenges Table 4. Specific IgE Blood Based Allergy Testing Industry Restraints Table 5. Global Specific IgE Blood Based Allergy Testing Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Specific IgE Blood Based Allergy Testing Revenue Share by Company (2021-2026) Table 7. Global Specific IgE Blood Based Allergy Testing Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Specific IgE Blood Based Allergy Testing Key Company Manufacturing Base & Headquarters Table 9. Global Specific IgE Blood Based Allergy Testing Company, Product Type & Application Table 10. Global Specific IgE Blood Based Allergy Testing Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Specific IgE Blood Based Allergy Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of ELISA Table 15. Significant Companies of FEIA Table 16. Significant Companies of Others Table 17. Global Specific IgE Blood Based Allergy Testing Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Specific IgE Blood Based Allergy Testing Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Specific IgE Blood Based Allergy Testing Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Specific IgE Blood Based Allergy Testing Sales Value Share by Type (2021-2026) Table 21. Global Specific IgE Blood Based Allergy Testing Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Hospitals Table 23. Significant Companies of Clinics Table 24. Significant Companies of Clinical Laboratories Table 25. Significant Companies of Others Table 26. Global Specific IgE Blood Based Allergy Testing Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Specific IgE Blood Based Allergy Testing Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Specific IgE Blood Based Allergy Testing Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Specific IgE Blood Based Allergy Testing Sales Value Share by Application (2021-2026) Table 30. Global Specific IgE Blood Based Allergy Testing Sales Value Share by Application (2027-2032) Table 31. Global Specific IgE Blood Based Allergy Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Specific IgE Blood Based Allergy Testing Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Specific IgE Blood Based Allergy Testing Sales Value Share by Region (2021-2026) Table 34. Global Specific IgE Blood Based Allergy Testing Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Specific IgE Blood Based Allergy Testing Sales Value Share by Region (2027-2032) Table 36. Global Specific IgE Blood Based Allergy Testing Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Specific IgE Blood Based Allergy Testing Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Specific IgE Blood Based Allergy Testing Sales Value Market Share by Country (2021-2026) Table 39. Global Specific IgE Blood Based Allergy Testing Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Specific IgE Blood Based Allergy Testing Sales Value Market Share by Country (2027-2032) Table 41. Phadia (Thermo Fisher Scientific) Company Information Table 42. Phadia (Thermo Fisher Scientific) Business Overview Table 43. Phadia (Thermo Fisher Scientific) Specific IgE Blood Based Allergy Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Phadia (Thermo Fisher Scientific) Specific IgE Blood Based Allergy Testing Product Portfolio Table 45. Phadia (Thermo Fisher Scientific) Recent Development Table 46. Medwiss Analytic Company Information Table 47. Medwiss Analytic Business Overview Table 48. Medwiss Analytic Specific IgE Blood Based Allergy Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Medwiss Analytic Specific IgE Blood Based Allergy Testing Product Portfolio Table 50. Medwiss Analytic Recent Development Table 51. Euroimmun Company Information Table 52. Euroimmun Business Overview Table 53. Euroimmun Specific IgE Blood Based Allergy Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Euroimmun Specific IgE Blood Based Allergy Testing Product Portfolio Table 55. Euroimmun Recent Development Table 56. Quest Diagnostics Company Information Table 57. Quest Diagnostics Business Overview Table 58. Quest Diagnostics Specific IgE Blood Based Allergy Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Quest Diagnostics Specific IgE Blood Based Allergy Testing Product Portfolio Table 60. Quest Diagnostics Recent Development Table 61. Eurofins Biomnis Company Information Table 62. Eurofins Biomnis Business Overview Table 63. Eurofins Biomnis Specific IgE Blood Based Allergy Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Eurofins Biomnis Specific IgE Blood Based Allergy Testing Product Portfolio Table 65. Eurofins Biomnis Recent Development Table 66. Siemens Healthineers Company Information Table 67. Siemens Healthineers Business Overview Table 68. Siemens Healthineers Specific IgE Blood Based Allergy Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Siemens Healthineers Specific IgE Blood Based Allergy Testing Product Portfolio Table 70. Siemens Healthineers Recent Development Table 71. Labcorp Company Information Table 72. Labcorp Business Overview Table 73. Labcorp Specific IgE Blood Based Allergy Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Labcorp Specific IgE Blood Based Allergy Testing Product Portfolio Table 75. Labcorp Recent Development Table 76. Novartis Company Information Table 77. Novartis Business Overview Table 78. Novartis Specific IgE Blood Based Allergy Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Novartis Specific IgE Blood Based Allergy Testing Product Portfolio Table 80. Novartis Recent Development Table 81. Omega Diagnostics Company Information Table 82. Omega Diagnostics Business Overview Table 83. Omega Diagnostics Specific IgE Blood Based Allergy Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Omega Diagnostics Specific IgE Blood Based Allergy Testing Product Portfolio Table 85. Omega Diagnostics Recent Development Table 86. Minaris Medical America Company Information Table 87. Minaris Medical America Business Overview Table 88. Minaris Medical America Specific IgE Blood Based Allergy Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Minaris Medical America Specific IgE Blood Based Allergy Testing Product Portfolio Table 90. Minaris Medical America Recent Development Table 91. MacroArray Diagnostics Company Information Table 92. MacroArray Diagnostics Business Overview Table 93. MacroArray Diagnostics Specific IgE Blood Based Allergy Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. MacroArray Diagnostics Specific IgE Blood Based Allergy Testing Product Portfolio Table 95. MacroArray Diagnostics Recent Development Table 96. DST Company Information Table 97. DST Business Overview Table 98. DST Specific IgE Blood Based Allergy Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. DST Specific IgE Blood Based Allergy Testing Product Portfolio Table 100. DST Recent Development Table 101. HYCOR Biomedical Company Information Table 102. HYCOR Biomedical Business Overview Table 103. HYCOR Biomedical Specific IgE Blood Based Allergy Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. HYCOR Biomedical Specific IgE Blood Based Allergy Testing Product Portfolio Table 105. HYCOR Biomedical Recent Development Table 106. Everlywell Company Information Table 107. Everlywell Business Overview Table 108. Everlywell Specific IgE Blood Based Allergy Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Everlywell Specific IgE Blood Based Allergy Testing Product Portfolio Table 110. Everlywell Recent Development Table 111. Abionic Company Information Table 112. Abionic Business Overview Table 113. Abionic Specific IgE Blood Based Allergy Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. Abionic Specific IgE Blood Based Allergy Testing Product Portfolio Table 115. Abionic Recent Development Table 116. Diagnostic Solutions Laboratory Company Information Table 117. Diagnostic Solutions Laboratory Business Overview Table 118. Diagnostic Solutions Laboratory Specific IgE Blood Based Allergy Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. Diagnostic Solutions Laboratory Specific IgE Blood Based Allergy Testing Product Portfolio Table 120. Diagnostic Solutions Laboratory Recent Development Table 121. MosaicDX Company Information Table 122. MosaicDX Business Overview Table 123. MosaicDX Specific IgE Blood Based Allergy Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. MosaicDX Specific IgE Blood Based Allergy Testing Product Portfolio Table 125. MosaicDX Recent Development Table 126. Lifelab Testing Company Information Table 127. Lifelab Testing Business Overview Table 128. Lifelab Testing Specific IgE Blood Based Allergy Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 129. Lifelab Testing Specific IgE Blood Based Allergy Testing Product Portfolio Table 130. Lifelab Testing Recent Development Table 131. HOB Biotech Group Company Information Table 132. HOB Biotech Group Business Overview Table 133. HOB Biotech Group Specific IgE Blood Based Allergy Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 134. HOB Biotech Group Specific IgE Blood Based Allergy Testing Product Portfolio Table 135. HOB Biotech Group Recent Development Table 136. Shenzhen Biocup Biotech Company Information Table 137. Shenzhen Biocup Biotech Business Overview Table 138. Shenzhen Biocup Biotech Specific IgE Blood Based Allergy Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 139. Shenzhen Biocup Biotech Specific IgE Blood Based Allergy Testing Product Portfolio Table 140. Shenzhen Biocup Biotech Recent Development Table 141. Hangzhou Zheda Dixun Biological Gene Engineering Company Information Table 142. Hangzhou Zheda Dixun Biological Gene Engineering Business Overview Table 143. Hangzhou Zheda Dixun Biological Gene Engineering Specific IgE Blood Based Allergy Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 144. Hangzhou Zheda Dixun Biological Gene Engineering Specific IgE Blood Based Allergy Testing Product Portfolio Table 145. Hangzhou Zheda Dixun Biological Gene Engineering Recent Development Table 146. ACON Biotech Company Information Table 147. ACON Biotech Business Overview Table 148. ACON Biotech Specific IgE Blood Based Allergy Testing Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 149. ACON Biotech Specific IgE Blood Based Allergy Testing Product Portfolio Table 150. ACON Biotech Recent Development Table 151. Research Programs/Design for This Report Table 152. Authors List of This Report Table 153. Secondary Sources Table 154. Primary Sources List of Figures Figure 1. Specific IgE Blood Based Allergy Testing Product Image Figure 2. Global Specific IgE Blood Based Allergy Testing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Specific IgE Blood Based Allergy Testing Market Size (2021-2032) & (US$ Million) Figure 4. Global Specific IgE Blood Based Allergy Testing Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. ELISA Image Figure 8. FEIA Image Figure 9. Others Image Figure 10. Global Specific IgE Blood Based Allergy Testing Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Specific IgE Blood Based Allergy Testing Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Specific IgE Blood Based Allergy Testing Sales Value Share by Type (2021-2032) Figure 13. Hospitals Image Figure 14. Clinics Image Figure 15. Clinical Laboratories Image Figure 16. Others Image Figure 17. Global Specific IgE Blood Based Allergy Testing Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Specific IgE Blood Based Allergy Testing Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Specific IgE Blood Based Allergy Testing Sales Value Share by Application (2021-2032) Figure 20. Global Specific IgE Blood Based Allergy Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Specific IgE Blood Based Allergy Testing Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Specific IgE Blood Based Allergy Testing Sales Value (2021-2032) & (US$ Million) Figure 23. North America Specific IgE Blood Based Allergy Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Specific IgE Blood Based Allergy Testing Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Specific IgE Blood Based Allergy Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Specific IgE Blood Based Allergy Testing Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Specific IgE Blood Based Allergy Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Specific IgE Blood Based Allergy Testing Sales Value (2021-2032) & (US$ Million) Figure 29. South America Specific IgE Blood Based Allergy Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Specific IgE Blood Based Allergy Testing Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Specific IgE Blood Based Allergy Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Specific IgE Blood Based Allergy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Specific IgE Blood Based Allergy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Specific IgE Blood Based Allergy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Specific IgE Blood Based Allergy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Specific IgE Blood Based Allergy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Specific IgE Blood Based Allergy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Specific IgE Blood Based Allergy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Specific IgE Blood Based Allergy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Specific IgE Blood Based Allergy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Specific IgE Blood Based Allergy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Specific IgE Blood Based Allergy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Specific IgE Blood Based Allergy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Specific IgE Blood Based Allergy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Specific IgE Blood Based Allergy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Specific IgE Blood Based Allergy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Specific IgE Blood Based Allergy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Specific IgE Blood Based Allergy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Specific IgE Blood Based Allergy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Specific IgE Blood Based Allergy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Specific IgE Blood Based Allergy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Specific IgE Blood Based Allergy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Specific IgE Blood Based Allergy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Specific IgE Blood Based Allergy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Specific IgE Blood Based Allergy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Specific IgE Blood Based Allergy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Specific IgE Blood Based Allergy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Specific IgE Blood Based Allergy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Specific IgE Blood Based Allergy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Specific IgE Blood Based Allergy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Specific IgE Blood Based Allergy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Specific IgE Blood Based Allergy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Specific IgE Blood Based Allergy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Specific IgE Blood Based Allergy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Specific IgE Blood Based Allergy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Specific IgE Blood Based Allergy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Specific IgE Blood Based Allergy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Specific IgE Blood Based Allergy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Specific IgE Blood Based Allergy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Specific IgE Blood Based Allergy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Specific IgE Blood Based Allergy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Specific IgE Blood Based Allergy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Specific IgE Blood Based Allergy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Specific IgE Blood Based Allergy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Specific IgE Blood Based Allergy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Specific IgE Blood Based Allergy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Specific IgE Blood Based Allergy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Specific IgE Blood Based Allergy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Specific IgE Blood Based Allergy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Specific IgE Blood Based Allergy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Specific IgE Blood Based Allergy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Specific IgE Blood Based Allergy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Specific IgE Blood Based Allergy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Specific IgE Blood Based Allergy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Specific IgE Blood Based Allergy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Specific IgE Blood Based Allergy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Specific IgE Blood Based Allergy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Specific IgE Blood Based Allergy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Specific IgE Blood Based Allergy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Specific IgE Blood Based Allergy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Specific IgE Blood Based Allergy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Specific IgE Blood Based Allergy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Specific IgE Blood Based Allergy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Specific IgE Blood Based Allergy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Specific IgE Blood Based Allergy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Specific IgE Blood Based Allergy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Specific IgE Blood Based Allergy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Specific IgE Blood Based Allergy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Specific IgE Blood Based Allergy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Specific IgE Blood Based Allergy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Specific IgE Blood Based Allergy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Specific IgE Blood Based Allergy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Specific IgE Blood Based Allergy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Specific IgE Blood Based Allergy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Specific IgE Blood Based Allergy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Specific IgE Blood Based Allergy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Specific IgE Blood Based Allergy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Specific IgE Blood Based Allergy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Specific IgE Blood Based Allergy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Specific IgE Blood Based Allergy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Specific IgE Blood Based Allergy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Specific IgE Blood Based Allergy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Specific IgE Blood Based Allergy Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Specific IgE Blood Based Allergy Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Specific IgE Blood Based Allergy Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • ELISA
  • FEIA
  • Others
Applications
  • Hospitals
  • Clinics
  • Clinical Laboratories
  • Others
Companies covered
  • Phadia (Thermo Fisher Scientific)
  • Medwiss Analytic
  • Euroimmun
  • Quest Diagnostics
  • Eurofins Biomnis
  • Siemens Healthineers
  • Labcorp
  • Novartis
  • Omega Diagnostics
  • Minaris Medical America
  • MacroArray Diagnostics
  • DST
  • HYCOR Biomedical
  • Everlywell
  • Abionic
  • Diagnostic Solutions Laboratory
  • MosaicDX
  • Lifelab Testing
  • HOB Biotech Group
  • Shenzhen Biocup Biotech
  • Hangzhou Zheda Dixun Biological Gene Engineering
  • ACON Biotech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Specific IgE Blood Based Allergy Testing Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Specific IgE Blood Based Allergy Testing Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Specific IgE Blood Based Allergy Testing Market Dynamics
  1. 2.1 Specific IgE Blood Based Allergy Testing Industry Trends
  2. 2.2 Specific IgE Blood Based Allergy Testing Industry Drivers
  3. 2.3 Specific IgE Blood Based Allergy Testing Industry Opportunities and Challenges
  4. 2.4 Specific IgE Blood Based Allergy Testing Industry Restraints
3 Specific IgE Blood Based Allergy Testing Market by Company
  1. 3.1 Global Specific IgE Blood Based Allergy Testing Company Revenue Ranking in 2025
  2. 3.2 Global Specific IgE Blood Based Allergy Testing Revenue by Company (2021-2026)
  3. 3.3 Global Specific IgE Blood Based Allergy Testing Company Ranking (2024-2026)
  4. 3.4 Global Specific IgE Blood Based Allergy Testing Company Manufacturing Base and Headquarters
  5. 3.5 Global Specific IgE Blood Based Allergy Testing Company Product Type and Application
  6. 3.6 Global Specific IgE Blood Based Allergy Testing Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Specific IgE Blood Based Allergy Testing Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Specific IgE Blood Based Allergy Testing Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Specific IgE Blood Based Allergy Testing Market by Type
  1. 4.1 Specific IgE Blood Based Allergy Testing Type Introduction
  2. 4.1.1 ELISA
  3. 4.1.2 FEIA
  4. 4.1.3 Others
  5. 4.2 Global Specific IgE Blood Based Allergy Testing Sales Value by Type
  6. 4.2.1 Global Specific IgE Blood Based Allergy Testing Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Specific IgE Blood Based Allergy Testing Sales Value by Type (2021-2032)
  8. 4.2.3 Global Specific IgE Blood Based Allergy Testing Sales Value Share by Type (2021-2032)
5 Specific IgE Blood Based Allergy Testing Market by Application
  1. 5.1 Specific IgE Blood Based Allergy Testing Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Clinics
  4. 5.1.3 Clinical Laboratories
  5. 5.1.4 Others
  6. 5.2 Global Specific IgE Blood Based Allergy Testing Sales Value by Application
  7. 5.2.1 Global Specific IgE Blood Based Allergy Testing Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Specific IgE Blood Based Allergy Testing Sales Value by Application (2021-2032)
  9. 5.2.3 Global Specific IgE Blood Based Allergy Testing Sales Value Share by Application (2021-2032)
6 Specific IgE Blood Based Allergy Testing Regional Value Analysis
  1. 6.1 Global Specific IgE Blood Based Allergy Testing Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Specific IgE Blood Based Allergy Testing Sales Value by Region (2021-2032)
  3. 6.2.1 Global Specific IgE Blood Based Allergy Testing Sales Value by Region: 2021-2026
  4. 6.2.2 Global Specific IgE Blood Based Allergy Testing Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Specific IgE Blood Based Allergy Testing Sales Value (2021-2032)
  7. 6.3.2 North America Specific IgE Blood Based Allergy Testing Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Specific IgE Blood Based Allergy Testing Sales Value (2021-2032)
  10. 6.4.2 Europe Specific IgE Blood Based Allergy Testing Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Specific IgE Blood Based Allergy Testing Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Specific IgE Blood Based Allergy Testing Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Specific IgE Blood Based Allergy Testing Sales Value (2021-2032)
  16. 6.6.2 South America Specific IgE Blood Based Allergy Testing Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Specific IgE Blood Based Allergy Testing Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Specific IgE Blood Based Allergy Testing Sales Value Share by Country, 2025 VS 2032
7 Specific IgE Blood Based Allergy Testing Country-level Value Analysis
  1. 7.1 Global Specific IgE Blood Based Allergy Testing Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Specific IgE Blood Based Allergy Testing Sales Value by Country (2021-2032)
  3. 7.2.1 Global Specific IgE Blood Based Allergy Testing Sales Value by Country (2021-2026)
  4. 7.2.2 Global Specific IgE Blood Based Allergy Testing Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Specific IgE Blood Based Allergy Testing Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Specific IgE Blood Based Allergy Testing Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Specific IgE Blood Based Allergy Testing Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Specific IgE Blood Based Allergy Testing Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Specific IgE Blood Based Allergy Testing Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Specific IgE Blood Based Allergy Testing Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Specific IgE Blood Based Allergy Testing Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Specific IgE Blood Based Allergy Testing Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Specific IgE Blood Based Allergy Testing Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Specific IgE Blood Based Allergy Testing Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Specific IgE Blood Based Allergy Testing Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Specific IgE Blood Based Allergy Testing Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Specific IgE Blood Based Allergy Testing Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Specific IgE Blood Based Allergy Testing Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Specific IgE Blood Based Allergy Testing Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Specific IgE Blood Based Allergy Testing Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Specific IgE Blood Based Allergy Testing Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Specific IgE Blood Based Allergy Testing Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Specific IgE Blood Based Allergy Testing Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Specific IgE Blood Based Allergy Testing Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Specific IgE Blood Based Allergy Testing Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Specific IgE Blood Based Allergy Testing Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Specific IgE Blood Based Allergy Testing Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Specific IgE Blood Based Allergy Testing Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Specific IgE Blood Based Allergy Testing Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Specific IgE Blood Based Allergy Testing Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Specific IgE Blood Based Allergy Testing Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Specific IgE Blood Based Allergy Testing Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Specific IgE Blood Based Allergy Testing Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Specific IgE Blood Based Allergy Testing Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Specific IgE Blood Based Allergy Testing Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Specific IgE Blood Based Allergy Testing Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Specific IgE Blood Based Allergy Testing Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Specific IgE Blood Based Allergy Testing Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Specific IgE Blood Based Allergy Testing Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Specific IgE Blood Based Allergy Testing Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Specific IgE Blood Based Allergy Testing Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Specific IgE Blood Based Allergy Testing Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Specific IgE Blood Based Allergy Testing Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Specific IgE Blood Based Allergy Testing Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Specific IgE Blood Based Allergy Testing Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Specific IgE Blood Based Allergy Testing Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Specific IgE Blood Based Allergy Testing Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Specific IgE Blood Based Allergy Testing Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Specific IgE Blood Based Allergy Testing Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Specific IgE Blood Based Allergy Testing Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Specific IgE Blood Based Allergy Testing Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Specific IgE Blood Based Allergy Testing Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Specific IgE Blood Based Allergy Testing Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Specific IgE Blood Based Allergy Testing Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Specific IgE Blood Based Allergy Testing Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Specific IgE Blood Based Allergy Testing Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Specific IgE Blood Based Allergy Testing Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Specific IgE Blood Based Allergy Testing Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Specific IgE Blood Based Allergy Testing Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Specific IgE Blood Based Allergy Testing Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Specific IgE Blood Based Allergy Testing Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Specific IgE Blood Based Allergy Testing Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Specific IgE Blood Based Allergy Testing Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Specific IgE Blood Based Allergy Testing Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Specific IgE Blood Based Allergy Testing Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Specific IgE Blood Based Allergy Testing Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Specific IgE Blood Based Allergy Testing Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Specific IgE Blood Based Allergy Testing Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Specific IgE Blood Based Allergy Testing Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Specific IgE Blood Based Allergy Testing Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Specific IgE Blood Based Allergy Testing Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Specific IgE Blood Based Allergy Testing Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Specific IgE Blood Based Allergy Testing Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Specific IgE Blood Based Allergy Testing Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Specific IgE Blood Based Allergy Testing Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Specific IgE Blood Based Allergy Testing Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Specific IgE Blood Based Allergy Testing Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Specific IgE Blood Based Allergy Testing Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Specific IgE Blood Based Allergy Testing Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Specific IgE Blood Based Allergy Testing Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Specific IgE Blood Based Allergy Testing Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Specific IgE Blood Based Allergy Testing Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Specific IgE Blood Based Allergy Testing Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Specific IgE Blood Based Allergy Testing Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Specific IgE Blood Based Allergy Testing Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Specific IgE Blood Based Allergy Testing Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Specific IgE Blood Based Allergy Testing Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Specific IgE Blood Based Allergy Testing Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Phadia (Thermo Fisher Scientific)
  2. 8.1.1 Phadia (Thermo Fisher Scientific) Company Information
  3. 8.1.2 Phadia (Thermo Fisher Scientific) Business Overview
  4. 8.1.3 Phadia (Thermo Fisher Scientific) Specific IgE Blood Based Allergy Testing Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Phadia (Thermo Fisher Scientific) Specific IgE Blood Based Allergy Testing Product Portfolio
  6. 8.1.5 Phadia (Thermo Fisher Scientific) Recent Developments
  7. 8.2 Medwiss Analytic
  8. 8.2.1 Medwiss Analytic Company Information
  9. 8.2.2 Medwiss Analytic Business Overview
  10. 8.2.3 Medwiss Analytic Specific IgE Blood Based Allergy Testing Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Medwiss Analytic Specific IgE Blood Based Allergy Testing Product Portfolio
  12. 8.2.5 Medwiss Analytic Recent Developments
  13. 8.3 Euroimmun
  14. 8.3.1 Euroimmun Company Information
  15. 8.3.2 Euroimmun Business Overview
  16. 8.3.3 Euroimmun Specific IgE Blood Based Allergy Testing Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Euroimmun Specific IgE Blood Based Allergy Testing Product Portfolio
  18. 8.3.5 Euroimmun Recent Developments
  19. 8.4 Quest Diagnostics
  20. 8.4.1 Quest Diagnostics Company Information
  21. 8.4.2 Quest Diagnostics Business Overview
  22. 8.4.3 Quest Diagnostics Specific IgE Blood Based Allergy Testing Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Quest Diagnostics Specific IgE Blood Based Allergy Testing Product Portfolio
  24. 8.4.5 Quest Diagnostics Recent Developments
  25. 8.5 Eurofins Biomnis
  26. 8.5.1 Eurofins Biomnis Company Information
  27. 8.5.2 Eurofins Biomnis Business Overview
  28. 8.5.3 Eurofins Biomnis Specific IgE Blood Based Allergy Testing Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Eurofins Biomnis Specific IgE Blood Based Allergy Testing Product Portfolio
  30. 8.5.5 Eurofins Biomnis Recent Developments
  31. 8.6 Siemens Healthineers
  32. 8.6.1 Siemens Healthineers Company Information
  33. 8.6.2 Siemens Healthineers Business Overview
  34. 8.6.3 Siemens Healthineers Specific IgE Blood Based Allergy Testing Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Siemens Healthineers Specific IgE Blood Based Allergy Testing Product Portfolio
  36. 8.6.5 Siemens Healthineers Recent Developments
  37. 8.7 Labcorp
  38. 8.7.1 Labcorp Company Information
  39. 8.7.2 Labcorp Business Overview
  40. 8.7.3 Labcorp Specific IgE Blood Based Allergy Testing Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Labcorp Specific IgE Blood Based Allergy Testing Product Portfolio
  42. 8.7.5 Labcorp Recent Developments
  43. 8.8 Novartis
  44. 8.8.1 Novartis Company Information
  45. 8.8.2 Novartis Business Overview
  46. 8.8.3 Novartis Specific IgE Blood Based Allergy Testing Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Novartis Specific IgE Blood Based Allergy Testing Product Portfolio
  48. 8.8.5 Novartis Recent Developments
  49. 8.9 Omega Diagnostics
  50. 8.9.1 Omega Diagnostics Company Information
  51. 8.9.2 Omega Diagnostics Business Overview
  52. 8.9.3 Omega Diagnostics Specific IgE Blood Based Allergy Testing Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Omega Diagnostics Specific IgE Blood Based Allergy Testing Product Portfolio
  54. 8.9.5 Omega Diagnostics Recent Developments
  55. 8.10 Minaris Medical America
  56. 8.10.1 Minaris Medical America Company Information
  57. 8.10.2 Minaris Medical America Business Overview
  58. 8.10.3 Minaris Medical America Specific IgE Blood Based Allergy Testing Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Minaris Medical America Specific IgE Blood Based Allergy Testing Product Portfolio
  60. 8.10.5 Minaris Medical America Recent Developments
  61. 8.11 MacroArray Diagnostics
  62. 8.11.1 MacroArray Diagnostics Company Information
  63. 8.11.2 MacroArray Diagnostics Business Overview
  64. 8.11.3 MacroArray Diagnostics Specific IgE Blood Based Allergy Testing Revenue and Gross Margin (2021-2026)
  65. 8.11.4 MacroArray Diagnostics Specific IgE Blood Based Allergy Testing Product Portfolio
  66. 8.11.5 MacroArray Diagnostics Recent Developments
  67. 8.12 DST
  68. 8.12.1 DST Company Information
  69. 8.12.2 DST Business Overview
  70. 8.12.3 DST Specific IgE Blood Based Allergy Testing Revenue and Gross Margin (2021-2026)
  71. 8.12.4 DST Specific IgE Blood Based Allergy Testing Product Portfolio
  72. 8.12.5 DST Recent Developments
  73. 8.13 HYCOR Biomedical
  74. 8.13.1 HYCOR Biomedical Company Information
  75. 8.13.2 HYCOR Biomedical Business Overview
  76. 8.13.3 HYCOR Biomedical Specific IgE Blood Based Allergy Testing Revenue and Gross Margin (2021-2026)
  77. 8.13.4 HYCOR Biomedical Specific IgE Blood Based Allergy Testing Product Portfolio
  78. 8.13.5 HYCOR Biomedical Recent Developments
  79. 8.14 Everlywell
  80. 8.14.1 Everlywell Company Information
  81. 8.14.2 Everlywell Business Overview
  82. 8.14.3 Everlywell Specific IgE Blood Based Allergy Testing Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Everlywell Specific IgE Blood Based Allergy Testing Product Portfolio
  84. 8.14.5 Everlywell Recent Developments
  85. 8.15 Abionic
  86. 8.15.1 Abionic Company Information
  87. 8.15.2 Abionic Business Overview
  88. 8.15.3 Abionic Specific IgE Blood Based Allergy Testing Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Abionic Specific IgE Blood Based Allergy Testing Product Portfolio
  90. 8.15.5 Abionic Recent Developments
  91. 8.16 Diagnostic Solutions Laboratory
  92. 8.16.1 Diagnostic Solutions Laboratory Company Information
  93. 8.16.2 Diagnostic Solutions Laboratory Business Overview
  94. 8.16.3 Diagnostic Solutions Laboratory Specific IgE Blood Based Allergy Testing Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Diagnostic Solutions Laboratory Specific IgE Blood Based Allergy Testing Product Portfolio
  96. 8.16.5 Diagnostic Solutions Laboratory Recent Developments
  97. 8.17 MosaicDX
  98. 8.17.1 MosaicDX Company Information
  99. 8.17.2 MosaicDX Business Overview
  100. 8.17.3 MosaicDX Specific IgE Blood Based Allergy Testing Revenue and Gross Margin (2021-2026)
  101. 8.17.4 MosaicDX Specific IgE Blood Based Allergy Testing Product Portfolio
  102. 8.17.5 MosaicDX Recent Developments
  103. 8.18 Lifelab Testing
  104. 8.18.1 Lifelab Testing Company Information
  105. 8.18.2 Lifelab Testing Business Overview
  106. 8.18.3 Lifelab Testing Specific IgE Blood Based Allergy Testing Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Lifelab Testing Specific IgE Blood Based Allergy Testing Product Portfolio
  108. 8.18.5 Lifelab Testing Recent Developments
  109. 8.19 HOB Biotech Group
  110. 8.19.1 HOB Biotech Group Company Information
  111. 8.19.2 HOB Biotech Group Business Overview
  112. 8.19.3 HOB Biotech Group Specific IgE Blood Based Allergy Testing Revenue and Gross Margin (2021-2026)
  113. 8.19.4 HOB Biotech Group Specific IgE Blood Based Allergy Testing Product Portfolio
  114. 8.19.5 HOB Biotech Group Recent Developments
  115. 8.20 Shenzhen Biocup Biotech
  116. 8.20.1 Shenzhen Biocup Biotech Company Information
  117. 8.20.2 Shenzhen Biocup Biotech Business Overview
  118. 8.20.3 Shenzhen Biocup Biotech Specific IgE Blood Based Allergy Testing Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Shenzhen Biocup Biotech Specific IgE Blood Based Allergy Testing Product Portfolio
  120. 8.20.5 Shenzhen Biocup Biotech Recent Developments
  121. 8.21 Hangzhou Zheda Dixun Biological Gene Engineering
  122. 8.21.1 Hangzhou Zheda Dixun Biological Gene Engineering Company Information
  123. 8.21.2 Hangzhou Zheda Dixun Biological Gene Engineering Business Overview
  124. 8.21.3 Hangzhou Zheda Dixun Biological Gene Engineering Specific IgE Blood Based Allergy Testing Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Hangzhou Zheda Dixun Biological Gene Engineering Specific IgE Blood Based Allergy Testing Product Portfolio
  126. 8.21.5 Hangzhou Zheda Dixun Biological Gene Engineering Recent Developments
  127. 8.22 ACON Biotech
  128. 8.22.1 ACON Biotech Company Information
  129. 8.22.2 ACON Biotech Business Overview
  130. 8.22.3 ACON Biotech Specific IgE Blood Based Allergy Testing Revenue and Gross Margin (2021-2026)
  131. 8.22.4 ACON Biotech Specific IgE Blood Based Allergy Testing Product Portfolio
  132. 8.22.5 ACON Biotech Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst